The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia
Clinical trial NCT04781114 · COMPLETED
Trial details
- NCT number
- NCT04781114
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-23
- Primary completion
- 2022-05-25
- Enrollment
- 806
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.